(Q27147887)
Statements
1 reference
1 February 2021
577.155731±0 dalton
1 reference
Vitexin 2''-O-beta-L-rhamnoside (English)
8 October 2016
CC1C(C(C(C(O1)OC2C(C(C(OC2C3=C4C(=C(C=C3[O-])O)C(=O)C=C(O4)C5=CC=C(C=C5)O)CO)O)O)O)O)O
1 reference
Vitexin 2''-O-beta-L-rhamnoside (English)
8 October 2016
C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2C3=C4C(=C(C=C3[O-])O)C(=O)C=C(O4)C5=CC=C(C=C5)O)CO)O)O)O)O)O
1 reference
Vitexin 2''-O-beta-L-rhamnoside (English)
8 October 2016
Identifiers
1 reference
Vitexin 2''-O-beta-L-rhamnoside (English)
8 October 2016
2 references
Vitexin 2''-O-beta-L-rhamnoside (English)
8 October 2016
1 reference
(1S)-1,5-Anhydro-2-O-(6-deoxy-beta-L-mannopyranosyl)-1-[5-hydroxy-2-(4-hydroxyphenyl)-7-oxido-4-oxo-4H-chromen-8-yl]-D-glucitol (English)
8 October 2016
2 references
Vitexin 2''-O-beta-L-rhamnoside (English)
8 October 2016
2 references